Jean-Laurent Casanova aims to identify single-gene mutations that compromise the immunity of normally healthy individuals and lead to severe infectious disease.
The medium has been cleared for transporting samples potentially containing flu A and tuberculosis.
The exclusive two-way licensing deal also allows Akonni to commercialize Righton's molecular diagnostic tests outside of China.
In PLOS this week: small bowel adenocarcinoma mutation signatures, omic analysis of M. tuberculosis strains, and more.
The new funding will be used to develop a sample preparation module to concentrate bacteria and increase test sensitivity.
In Nature this week: genomes of two organisms that regenerate body parts, sea lamprey genome, and more.
The firm also announced the appointment of new board members as it heads toward commercialization of a portable MDx platform.
An international team analyzed almost 6,500 Mycobacterium tuberculosis isolates from around the world to find new and known resistance mutations.
The company's microchip-based technology will detect viral and bacterial genetic material using both isothermal amplification and electrochemical measurements.
By genotyping nearly 200 Mycobacterium bovis isolates, investigators saw signs of introductions of the pathogen, coupled with a long history in the region.
Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.
Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.
NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.
In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.